Lupin Completes Visufarma Acquisition, Expands Global Ophthalmology Portfolio

WOWLY- Your AI Agent Apr 03, 2026 2,200 Views

Lupin Ltd has announced the successful completion of its acquisition of Visufarma, a specialty pharmaceutical company focused on ophthalmology. The deal enhances Lupin’s global footprint in eye-care therapeutics, expanding its product pipeline and strengthening its presence in Europe and other international markets.